Substance abuse and addictive disorders constitute a major, high-impact health problem. This competitive renewal of the training grant Neural and Pharmacological Mechanisms of Abused Drugs (T32DA07287) at the University of Texas Medical Branch (UTMB) proposes to address the large gap between the problem of addiction and efficacious solutions by mentoring the next generation of scientists prepared and committed to the search for answers. The overarching goal of the Training Program is to provide nascent scientists with the knowledge base, technical expertise and professional skills needed to advance knowledge in the addictions and to move these advances toward new therapeutics. The 22 faculty mentors/co-mentors have a wealth of training and career development successes, extensive collaborative networks and expertise in translational addiction research conducted with modern technologies. Our objectives are to provide exemplary training in translational research in the neural bases for drug abuse and addiction, drug discovery and medications development, and the medical consequences of drug abuse and addiction. Strategies to achieve these objectives include providing well-funded, state-of-the-art research opportunities and facilities, effective mentoring and monitoring plans, challenging curricula and supportive interactive programs (e.g., short-term clinical rotations, journal clubs, workgroups, seminars), and first-rate program activities that develop the professional skills needed for advancement towards an independent career. The culmination of our efforts is the success of our trainees as complete, contemporary scientists equipped with the tools to advance the mechanistic understanding of addiction and move these advances toward new therapeutic approaches to its treatment.
This Training Program will mentor the next generation of investigators equipped to uncover the neural bases for addiction, conduct drug discovery and medication development research for new addiction therapies, and understand the medical consequences of addictive disorders. The outcomes will result in greater understanding of, and potential therapeutics for chronic addictive disorders that dramatically impact the health of U. S. citizens.
|Benzon, C R; Johnson, S B; McCue, D L et al. (2014) Neuromedin U receptor 2 knockdown in the paraventricular nucleus modifies behavioral responses to obesogenic high-fat food and leads to increased body weight. Neuroscience 258:270-9|
|Kasper, James M; Johnson, Sarah B; Hommel, Jonathan D (2014) Fat Preference: a novel model of eating behavior in rats. J Vis Exp :e51575|
|Timpe, Jennifer M; Wang, Cheng Z; Kim, Jisoo et al. (2014) ?-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor activation protects against phencyclidine-induced caspase-3 activity by activating voltage-gated calcium channels. J Neurosci Res 92:1785-91|
|Anastasio, Noelle C; Stoffel, Erin C; Fox, Robert G et al. (2011) Serotonin (5-hydroxytryptamine) 5-HT(2A) receptor: association with inherent and cocaine-evoked behavioral disinhibition in rats. Behav Pharmacol 22:248-61|
|Alyea, Rebecca A; Watson, Cheryl S (2009) Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17beta-estradiol. Environ Health Perspect 117:778-83|
|Alyea, Rebecca A; Watson, Cheryl S (2009) Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux. BMC Neurosci 10:59|
|Alyea, Rebecca A; Laurence, Stephanie E; Kim, Sung H et al. (2008) The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J Neurochem 106:1525-33|
|Stoffel, Erin C; Cunningham, Kathryn A (2008) The relationship between the locomotor response to a novel environment and behavioral disinhibition in rats. Drug Alcohol Depend 92:69-78|
|Anastasio, Noelle C; Johnson, Kenneth M (2008) Differential regulation of the NMDA receptor by acute and sub-chronic phencyclidine administration in the developing rat. J Neurochem 104:1210-8|
|Bubar, M J; Cunningham, K A (2007) Distribution of serotonin 5-HT2C receptors in the ventral tegmental area. Neuroscience 146:286-97|
Showing the most recent 10 out of 22 publications